Journal of Health Care and Prevention
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Case Report   
  • J Health Care Prev 2022, Vol 5(6): 179

Outline of Low-Dose Gabapentin in a Pediatric Patient of Case Presentation

Dr. Clara Wang*
School of Medicine, University of California, Irvine, 1001 Health Sciences Rd, Irvine, CA 92617, USA
*Corresponding Author : Dr. Clara Wang, School of Medicine, University of California, Irvine, 1001 Health Sciences Rd, Irvine, CA 92617, USA, Email: claraang12@gmail.com

Received Date: Oct 15, 2022 / Accepted Date: Nov 10, 2022 / Published Date: Nov 11, 2022

Abstract

Although rare, primary erythromelalgia can have a major negative impact on a person's quality of life. There is no accepted standard of care for erythromelalgia, despite the fact that many individuals with this ailment need systemic therapy. Here, we present the case of a 7-year-old girl who, following therapy with low-dose gabapentin had her erythromelalgia symptoms resolve without any negative side effects. We also go through the effectiveness and safety of using low-dose gabapentin to relieve pain in youngsters.

Citation: Wang C (2022) Outline of Low-Dose Gabapentin in a Pediatric Patient of Case Presentation. J Health Care Prev, 5: 179.

Copyright: © 2022 Wang C. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top